Skin patch testosterone tested as new weapon against tough prostate cancer
NCT ID NCT03734653
Summary
This early-stage study tested a new approach for men with advanced prostate cancer that has stopped responding to standard hormone-blocking therapy. Researchers wanted to see if it was practical and safe to give testosterone through a skin patch, alternating with a cancer drug called enzalutamide. The goal was to see if this method could control the cancer while potentially causing fewer side effects than testosterone injections.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Colorado Hospital
Aurora, Colorado, 80045, United States
Conditions
Explore the condition pages connected to this study.